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Genome-wide association analysis identiﬁes novel
loci for chronotype in 100,420 individuals from the
UK Biobank
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Our sleep timing preference, or chronotype, is a manifestation of our internal biological clock.
Variation in chronotype has been linked to sleep disorders, cognitive and physical
performance, and chronic disease. Here we perform a genome-wide association study of
self-reported chronotype within the UK Biobank cohort (n¼ 100,420). We identify 12 new
genetic loci that implicate known components of the circadian clock machinery and point
to previously unstudied genetic variants and candidate genes that might modulate core
circadian rhythms or light-sensing pathways. Pathway analyses highlight central nervous and
ocular systems and fear-response-related processes. Genetic correlation analysis suggests
chronotype shares underlying genetic pathways with schizophrenia, educational attainment
and possibly BMI. Further, Mendelian randomization suggests that evening chronotype relates
to higher educational attainment. These results not only expand our knowledge of the
circadian system in humans but also expose the inﬂuence of circadian characteristics over
human health and life-history variables such as educational attainment.
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C
hronotype is a behavioural manifestation of our internal
timing system, the circadian clock. Individual variation
within our biological clock drives our morning or evening
preferences, thereby making us into ‘morning larks’ or ‘night
owls’. Chronotype is inﬂuenced by many factors, including age,
sex, social constraints and environmental factors, among others1.
Chronotype has been associated with sleep disorders, cognitive
and physical performance, chronic metabolic and neurologic
disease, cancer and premature aging2, in particular when there is
desynchrony between internal chronotype and external
environment increasing disease risk3. Despite the importance of
circadian rhythms to human health and their fundamental role
demonstrated in model organisms4,5, little is known about the
biological mechanisms underlying inter-individual variation in
human chronotype or how it impacts our health and physiology.
Genes that encode molecular components of the core circadian
clock (PER2, PER3) or regulate the pace of the clock (CSNK1D)
are disrupted in Advanced Sleep Phase Syndrome (ASPS) and
Delayed Sleep Phase Syndrome both of which are monogenic
circadian rhythm disorders causing extreme advance or delay in
sleep onset6. ASPS mutations shorten circadian period in humans
and mice7,8, linking the change in pace of the clock with sleep
timing preference. More detailed biochemical and functional
characterization of these mutations have greatly enhanced our
understanding of the mechanisms regulating the circadian clock.
Emerging evidence suggests that subjects with ASPS may be at
increased risk for chronic disease, such as cardio-metabolic
disease9 or migraine10.
In addition to monogenic sleep phase disorders, pronounced
inter-individual variation in chronotype exists within the general
population5, and epidemiologic associations with adverse health
outcomes have been reported2,11. Chronotype is heritable as
estimated by twin and family studies (12–42%)12–14 but its
genetic basis has not yet been well deﬁned. Candidate gene
association studies have reported variation associated with
morningness or eveningness preference in the CLOCK, PER1,
PER2 and PER3 genes15; however, these studies have often had
limited reproducibility, suffering from small sample sizes,
heterogeneity in chronotype assessment and inadequate
correction for population structure. Recently, a genome-wide
association study (GWAS) for self-reported habitual bedtime
identiﬁed variation in NPSR112, but again robust replication of
this ﬁnding has not been reported. Nonetheless, these studies
suggest that novel genetic loci for chronotype, like for other
complex traits, may be identiﬁed by GWAS provided that
sufﬁciently large cohorts are used.
To deﬁne the spectrum of genetic variation contributing to
variation in human circadian phenotype, and identify associative
or causal links between chronotype and other health indices, we
perform the largest GWAS of self-reported chronotype to date,
within the UK Biobank cohort (n¼ 100,420), a unique resource
with an extensive set of individual life history parameters.
Self-reported chronotype has been validated in previous studies,
and correlates signiﬁcantly with objectively measured physiolo-
gical rhythms16. Our work identiﬁes several novel genetic loci
that associate signiﬁcantly with chronotype, and importantly
reveals a signiﬁcant genetic correlation between chronotype and
schizophrenia risk, BMI and educational attainment.
Results
Twelve genome-wide signiﬁcant association signals. Variation
in chronotype associated signiﬁcantly with age, sex, sleep
duration, depression and psychiatric medication use, with
‘eveningness’ being associated with younger age, being male,
having a longer sleep duration, being more likely to be depressed
or using psychiatric medication (Supplementary Table 1).
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Figure 1 | Manhattan and Q–Q plots for genome-wide association analysis of both continuous and extreme chronotype. Manhattan plots (a,c). Red line
is genome-wide signiﬁcant (5 108) and blue line is suggestive (1 10 6). Q–Q plots (b,d). Nearest gene name is annotated. Heritability estimates
were calculated using BOLT-REML and lambda inﬂation values using GenABEL in R.
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These characteristics together explained 1.4% of variation in
chronotype.
Two parallel primary GWAS analyses of genotyped and
imputed single nucleotide polymorphisms (SNPs) were per-
formed using regression models adjusting for age, sex, 10
principal components of ancestry and genotyping array: an
ordinal score of chronotype based on four categories from
‘deﬁnite morning’ to ‘deﬁnite evening’ treated as a continuous
trait, using the whole population (n¼ 100,420) and a binary
variable of chronotype extremes (8,724 deﬁnite evening-type
cases versus 26,948 deﬁnite morning-type controls), to enrich for
rarer variants expected to have stronger effects. In total, 12
genome-wide signiﬁcant loci were identiﬁed (Figs 1 and 2;
Table 1; and Supplementary Fig. 1; Po5 10 8) of which three
surpassed genome-wide signiﬁcance in both analyses (Table 1).
Association was observed near PER2, an ASPS gene, and three
other association signals were found in or near genes with a well-
known role in circadian rhythms (APH1A, RGS16 and FBXL13),
consistent with the hypothesis that circadian clock biology
contributes to variation in chronotype. Conditional analyses at
the 12 loci implicated one suggestive secondary association signal,
a missense variant (V903I) in the core circadian clock gene PER2
(P¼ 8.43 10 8) predicted to be damaging (Polyphen 0.984,
CADD scaled 16.21; Supplementary Table 2); thus, conﬁrming
that core circadian clock genes disrupted in ASPS harbour
common variants that contribute to variation in chronotype.
Together, in the discovery sample, the 12 loci explain 4.3% of
variance in chronotype. Credible set analyses17 highlight a limited
number of potential causal variants at each locus (Table 1).
Robustness of the self-reported chronotype trait and genetic
loci identiﬁed here was further validated by an independent
GWAS of extreme chronotype from Hu et al.18 In total, 8 of 15
reported loci replicated in our study, and all 15 showed a
consistent direction of effect in our study. Three additional loci
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Figure 2 | Regional association plots for genome-wide signiﬁcant chronotype loci. (a–i) show loci associated with continuous chronotype,
(j–l) show loci associated with extreme chronotype. Genes within the region are shown in the lower panel. The blue line indicates the recombination
rate. Filled circles show the  log10 P value for each SNP, with the lead SNP shown in purple. Additional SNPs in the locus are coloured according to
correlation (r2) with the lead SNP (estimated by LocusZoom based on the CEU HapMap haplotypes). *chr7 rs372229746 is not in the reference
panel, therefore LD data is unavailable for this SNP.
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attain genome-wide signiﬁcance in meta-analysis of both studies
using publicly available results for the 15 SNPs from Hu et al.
(near genes PER3, VIP and TOX3: Supplementary Table 3).
No evidence of association was observed for previously
reported SNPs from other candidate gene or GWA studies
(Supplementary Table 4). The PER3 VNTR (rs57875989)
previously associated with chronotype19 was not directly
genotyped or imputed in this study; nonetheless, a suggestive
association signal was observed encompassing this region of PER3
(lead SNP: rs7545893 P¼ 6.5 10 8; 33 kb from PER3 VNTR)
and largely independent from the lead 23andMe PER3 region
SNP (r2¼ 0.186 in 1KG CEU18; Supplementary Fig. 2).
Secondary analyses were performed on the 12 lead SNPs within
the chronotype loci, including (1) separate comparison of effects
on morningness and eveningness, (2) sex-speciﬁc analysis, (3)
pair-wise genetic interaction analysis and (4) regression models
including additional covariates. Comparison of case extremes
(8,724 evening or 26,948 morning) to the collapsed middle group
(n¼ 64,748) revealed three loci (LINC01128, APH1A, FAT1) with
stronger effects in the eveningness case–control analysis as
opposed to morningness analysis. A rare variant (0.2%) at the
LINC01128 locus (rs141175086C) exhibited the most striking
protective effect for eveningness (odds ratio (OR)¼ 0.22
(0.10–0.50), P¼ 1.7 10 5) but only a small risk effect for
morningness (OR¼ 1.30 (0.97–1.75), P¼ 0.08; Supplementary
Table 5). No signiﬁcant sex-speciﬁc effects (Supplementary
Table 6) or epistasis between loci (Supplementary Table 7) were
detected. Similarly, sensitivity analyses adjusting for factors
known to be associated with chronotype, including sleep duration
and disorders, depression and psychiatric medication use did
not signiﬁcantly alter the effect estimates or strength of the
associations (Supplementary Table 8).
Candidate causal genes at these loci are highlighted in
Supplementary Note 1. The 12 loci encompass 72 candidate
genes enriched in pathways for circadian rhythms (Padj¼ 0.014),
mental disorders (Padj¼ 0.001), sleep disorders (Padj¼ 0.005), the
spliceosome (Padj¼ 0.020) and Alzheimer’s disease (Padj¼ 0.030)
among others (Supplementary Table 9). In addition, four loci are
located in or near genes with a well-known role in circadian
rhythms (PER2, APH1A, RGS16 and FBXL13), however whether
these genes are responsible for the association signals observed
remains to be established. The remaining eight loci offer the
potential of novel biological insights into circadian rhythms
(Supplementary Note 1). Several candidate causal genes have
been implicated in circadian rhythms. TNRC6B controls circadian
behaviour in ﬂies20 and is bound by known circadian
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transcription factors in mouse liver21. MCL1 has rhythmically
expressed mRNA in liver22, disrupts circadian rhythms in an
RNAi screen using a human osteosarcoma cell line23, and is
bound by known circadian transcription factors in mouse liver21.
HTR6 is a G-protein-coupled receptor known to regulate the
sleep–wake cycle24–26.
Fine-mapping, sequencing and experimental studies are
necessary to identify the causal gene(s) and variant(s) at each
locus to understand mechanisms by which DNA variation
inﬂuences variation in chronotype. However, clues may emerge
from exploration of bioinformatic annotations of candidate
regulatory variants and ENCODe analyses of chromatin states
and bound proteins27. For example, rare variant rs141175086 is
predicted to disrupt a binding site for the known circadian
transcription factor DEC1 in an enhancer element within or
upstream of previously uncharacterized lincRNAs (LOC643837,
LINC01128).
Pathway analyses. Heritability of chronotype, captured by
genome-wide genotypes in this study, was estimated to be 19.4%
(continuous) and 37.7% (extreme) using GCTA28. Heritability
partitioning of continuous chronotype GWAS by tissue and
functional category using LD-score regression29 identiﬁed
enrichment in the central nervous system (enrichment 2.63,
P¼ 1.91 10 6) and adrenal/pancreatic tissues (enrichment
3.63, P¼ 1.34 10 8; Fig. 3a and Supplementary Table 10).
Regions of the genome annotated as highly conserved across
mammals30 (enrichment 14.33, P¼ 1.75 10 9), and in regions
of histone 3 lysine 4 monomethylation that mark active/poised
enhancer elements (enrichment 1.30, P¼ 0.0017; Fig. 3a and
Supplementary Table 10) were signiﬁcantly enriched, supporting
a key role of circadian rhythms throughout mammalian
evolution.
Gene-based analysis31 identiﬁed 23 genes signiﬁcantly
associated with chronotype (Po2.8 10 6, Supplementary
Table 11; Supplementary Fig. 3). Pathway analysis32 shows a
signiﬁcant enrichment in this gene set for genes previously
implicated in Alzheimer’s disease (Padj¼ 0.0176) and dementia
(Padj¼ 0.0192), eye abnormalities (Padj¼ 0.0176) and eye diseases
(Padj¼ 0.0253), chromosomal deletions (Padj¼ 0.0253), brain
diseases (Padj¼ 0.0253), central nervous system diseases
(Padj¼ 0.0253) and mental disorders (Padj¼ 0.0365). In support,
integrative analysis of signals with Po1 10 5 using DEPICT33,
a tool that uses predicted gene functions to prioritize genes, gene
sets and tissues, showed suggestive enrichment in gene sets
associated with ‘fear response’ and ‘behavioural defence response’
(False Discovery Rateo0.20), and central nervous and hemic/
immune system tissues (Supplementary Table 12). In total,
pathway analyses link the genetics of chronotype to central
nervous system function and neurological disorders including
dementia and affective disorders.
Genetic links with schizophrenia and educational attainment.
Given that circadian rhythms play a fundamental role in human
physiology, a key question is the extent to which the genetics of
chronotype is shared with other behavioural or disease states, and
importantly whether genetic relationships between chronotype
and other traits are causal. To address this, we tested for genetic
correlation of chronotype with GWAS variants for 19 phenotypes
spanning a range of cognitive, neuro-psychiatric, anthropometric,
cardio-metabolic and auto-immune traits using LD score
regression on chronotype GWAS and publicly available GWAS
for each trait34. Genetic correlations suggested that tendency
towards an evening chronotype is related to greater years of
education (rg (s.e.) 0.161 (0.041), P¼ 8.96 10 5) and increased
schizophrenia risk (rg (s.e.) 0.112 (0.034), P¼ 0.0011 (Fig. 3b;
Table 1 | Genome-wide signiﬁcant loci associated with chronotype in subjects of European ancestry in the UK Biobank.
SNP Chr:position
NCBI 37
Nearest
Gene
Alleles
(E/A)
EAF Continuous chronotype
(n¼ 100,420) (1–4 ranging
from ‘deﬁnite morning’ to
‘deﬁnite evening’)
Extreme chronotype
(n¼8,724 evening-type cases,
n¼26,948 morning-type
controls)
Most likely
causal SNPs
(probability)
Beta (s.e.) P value OR (95% CI) P value
rs141175086 1:780,397 LINC01128 C/T 0.998 0.266 (0.070) 1.42 104 2.16 (1.34 3.49) 4.38 108 rs141175086 (1.00)
rs2050122 1:19,989,205 HTR6 C/T 0.80 0.031 (0.006) 4.61 108 1.12 (1.07–1.17) 7.94 10 7 rs2050122 (0.385)
rs76681500 1:77,713,434 AK5 G/A 0.84 0.043 (0.006) 1.50 10 12 1.16 (1.10–1.22) 1.77 109 rs76681500 (0.665)
rs10157197 1:150,250,636 APH1A A/G 0.40 0.028 (0.005) 1.48 109 1.13 (1.09–1.17) 1.27 10 11 rs10157197 (0.085),
rs11205355 (0.085)
rs1144566 1:182,569,626 RGS16 C/T 0.97 0.099 (0.013) 2.62 10 14 1.35 (1.22–1.50) 1.29 108 rs1144566 (0.213),
rs694383 (0.213),
rs12743617 (0.213),
rs509476 (0.213)
rs11895698 2:239,338,495 ASB1 T/C 0.14 0.035 (0.006) 1.15 108 1.10 (1.05–1.15) 1.30 104 rs11895698 (0.279),
rs3769118 (0.279)
rs11708779 3:55,934,939 ERC2 G/A 0.65 0.026 (0.005) 3.08 108 1.09 (1.06–1.13) 1.20 106 rs11708779 (0.769)
rs148750727 4:188,022,952 FAT1 T/G 0.995 0.154 (0.033) 3.61 106 2.34 (1.69–3.23) 1.58 108 rs148750727 (1.00)
rs372229746 7:102,158,815 FBXL13 A/G 0.45 0.034 (0.005) 5.18 10 10 1.12 (1.07–1.16) 4.29 10 7 rs372229746 (1.00)
rs17311976 8:131,637,337 ADCY8 C/T 0.19 0.028 (0.006) 1.08 10 6 1.13 (1.08–1.18) 3.37 108 rs17311976 (0.346),
rs17311976 (0.165),
rs17311976 (0.107)
rs542675489 12:120,994,888 RNF10 C/CA 0.60 0.027 (0.005) 3.29 10 9 1.09 (1.05–1.13) 1.38 10 5 rs542675489 (1.00)
rs4821940 22:40,659,573 TNRC6B C/T 0.55 0.026 (0.004) 1.05 108 1.07 (1.04–1.11) 8.56 10 5 rs4821940 (0.172)
Suggestive secondary signal
rs35333999 2:239161957 PER2 T/C 0.043 0.059 (0.011) 8.43 108 1.21 (1.11–1.32) 9.01 10 6 rs35333999 (0.895)
A, alternative allele; Chr, chromosome; CI, conﬁdence interval; E, effect allele; EAF, effect allele frequency; OR, odds ratio; TSLS, two-stage-least-squares method..
Ancestral allele is indicated in bold. Candidate putative causal SNPs were identiﬁed by PICS17. Note, increasing beta and odds ratio indicate greater evening type preference.
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Supplementary Table 10). Genetic correlations also suggested
that a morning chronotype may share underlying biology
with increased BMI (rg (s.e.)  0.0851 (0.0281), P¼ 0.0025;
Fig. 3b; Supplementary Table 10).
Mendelian randomization analyses. To explore whether the
relationship between chronotype and traits with signiﬁcant
genetic correlations might be causal, we tested for association of a
risk score of genome-wide signiﬁcant chronotype SNPs from
23andMe18 with years of education, schizophrenia and BMI.
SNPs can be used as instrument variables to test for a causal
relationship between two traits, and because genotypes are
assigned randomly at meiosis, genetic association is not biased
by confounding or reverse causation possible in observational
epidemiology35,36. Since individuals do not know their genotype
any phenotypic misclassiﬁcation will be random with respect to
genotype. In the UK Biobank, a signiﬁcant association was
observed between a chronotype genetic risk score of SNPs related
to eveningness and increased educational attainment
(P¼ 0.0167), but not schizophrenia (P¼ 0.101) or BMI
(P¼ 0.285; Supplementary Table 13). Further instrumental
variable analyses suggested that for each increase in
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Figure 3 | Overall genetic architecture of chronotype across tissues, functional categories and cross-trait genetic correlation. (a) Enrichment estimates
for the main annotations and tissues of LDSC. Error bars represent 95% conﬁdence intervals around the estimate. Categories are sorted by P value, with
boxes indicating annotations or tissues that pass the multiple testing signiﬁcance threshold. (b) Chronotype regression estimates of genetic correlation
with the summary statistics from 19 publicly available genome-wide association studies of psychiatric and metabolic disorders, immune diseases and other
traits of natural variation. The horizontal axis indicates the phenotype compared with categorical chronotype and the vertical axis indicates genetic
correlation. Error bars are s.e’s. ADHD, attention deﬁcit hyperactivity disorder; BMI, body mass index; CNS, central nervous system; CTCF, CCCTC-binding
transcription factor; DHS, DNase hypersenstivity; GI, gastrointestinal; T2D, type 2 diabetes; TFBS, transcription factor binding site; Tss, transcription start
site; UTR, untranslated region.
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‘eveningness’ category, educational attainment increased by 7.5
months (P¼ 0.021) (Fig. 4; Supplementary Fig. 4; Supplementary
Table 13). We then tested for reverse causation by assessing
whether variation in education, schizophrenia or BMI might
cause variation in chronotype by testing for association of risk
scores for each of these traits obtained from prior large-scale
GWAS studies with chronotype. No signiﬁcant associations were
observed (Supplementary Table 13).
Discussion
In this largest GWAS of chronotype to date, we report the
discovery of 12 genetic loci associated with chronotype, and
pathway analysis suggests key roles of genes in the nervous and
ocular systems. Further, we demonstrate shared biology of
chronotype with schizophrenia, and possibly BMI, with a putative
causal link to educational attainment.
Several lines of evidence support these association signals as
true positives that may help to uncover new aspects of circadian
biology in humans. First, we detect signals in or near known
circadian genes at 4 of the 12 loci, including near and in PER2, a
clock gene previously associated with ASPS6. Second, three of
these signals have been observed in an independent GWAS18
suggesting independent validation of our ﬁndings. Third, novel
associated loci include candidate central circadian clock genes
with rhythmic expression in the SCN or circadian behavioural
phenotypes in model organisms. Fourth, genes under association
peaks are enriched for central nervous system and ocular
processes, both important for generation of circadian rhythms.
Additional replication to conﬁrm chronotype genetic associations
and functional follow-up will be necessary to identify causal genes
and circuits disrupted by causal variants at these loci.
Our study also deﬁnes the genetic architecture of self-reported
chronotype, revealing heritability estimates consistent with
previous literature12–14, despite using a different questionnaire
instrument than previous studies16. The 12 genome-wide
signiﬁcant loci appear to explain a large fraction of chronotype
variance (4.3%) but this may be overestimated due to winners
curse, or may reﬂect lower polygenicity of chronotype than seen
for other complex traits, since variation in a limited number
of biological processes (light-sensing, core circadian clock
and limited downstream effectors) may be causal. Signiﬁcant
enrichment of heritability in highly conserved regions is
consistent with the strong conservation of circadian rhythms
throughout evolution37 and may aid in ﬁne mapping of causal
variants and creation of faithful animal models for future
experimental studies. Similarly, enrichment of heritability in
activating enhancer sites and borderline enrichment in
transcriptional start sites is consistent with the role of the
circadian molecular clock in ﬁne tuning of transcriptional
regulation23.
The association signals at loci identiﬁed by our study when
combined with signals from 23andMe cover genes identiﬁed in
GWAS for restless legs syndrome and Mendelian and model
organism studies of narcolepsy, suggesting overlap with other
sleep traits. Genetic variants in the region of TOX3 have been
previously associated with restless legs syndrome in a GWAS38.
Although the chronotype-associated variant (rs12927162) is not
in linkage disequilibrium with the lead restless legs syndrome
variant (rs3104767; r2o0.001 in 1KG CEU population), it does
suggest that TOX3 may have a broader role in basic sleep/
circadian physiology. In addition, rare forms of severe early onset
narcolepsy in humans39 and familial narcolepsy in canines40
are caused by mutations in HCRTR2, again suggesting shared
underlying biology.
Chronotype has previously been associated with many
behaviours and diseases, such as cardiovascular disease, type 2
diabetes, metabolic disorders, risk-taking behaviour, cancer,
psychiatric disorders and even creativity1,3. Comparing the
genetic architecture of chronotype captured in this study with
an initial series of select phenotypes with publicly available
GWAS data, we identiﬁed signiﬁcant genetic overlap between
chronotype and schizophrenia, educational attainment and
possibly BMI. Previous literature links evening chronotype with
schizophrenia41–43, consistent with our ﬁndings. These studies
also demonstrate severe circadian sleep/wake disruptions in
people with schizophrenia, indicating that this relationship may
be bidirectional. However, our Mendelian randomization analyses
did not support causal relationships between these two. It is
possible that even with our large sample size, we are under-
powered to rule out an effect of schizophrenia on chronotype.
We detect a surprising putative genetic link between morning
chronotype and higher BMI. Previous observational studies have
shown association of evening chronotype with higher
BMI, poorer dietary habits and decreased inhibitions44–47.
Consistently, we noted an association between evening
chronotype and BMI (beta¼ 1.003 BMI units/chronotype;
P¼ 1 10 4; r¼ 0.011). Our genetic correlation analyses
suggest the intriguing possibility that some underlying pathways
contributing to morning chronotype might also contribute to
increased BMI. However, independent replication and further
large studies are required to fully understand the genetic and
causal relationships between chronotype and BMI.
Until now, it has been difﬁcult to discern causal relationships
between chronotype and other traits because of potential biases in
observational studies, for example, due to confounding or reverse
causality, which are unlikely to affect genetic studies48. Our work
Chronotype
Unmeasured
confounders
+ 0.015
“eveningness”
units per allele P <0.0001
Mendelian randomization for
causal relationship of chronotype
on educational attainment:
= 0.625 (0.270), P =0.021
Chronotype
genetic risk
score
(15 SNPs)
+ 1.08 months per
chronotype P <0.0001
Age at
culmination of
education
+0.1 month/“eveningness” chronotype allele P =0.0167
Figure 4 | Mendelian Randomization. under the assumptions of instrumental variable Mendelian randomization analyses70, our results show that
having an evening chronotype results in higher educational attainment. In this analysis, for the chronotype risk score (comprised of 15 SNPs from the
23andMe GWAS of chronotype, weighted by effect size), the b coefﬁcient for the association with chronotype was regressed on the b-coefﬁcient for the
association with the main educational attainment trait in the UK Biobank (n¼68,718) using TSLS. TSLS, two-stage-least-squares method.
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suggests that tendency to eveningness chronotype is potentially
causally related to increased educational attainment, but
replication of these ﬁndings, and more comprehensive
assessment of potential sources of bias will require future
investigation. Previous studies have reported that night owls
earn a larger mean income than their earlier rising
counterparts49. Another study, performed at a top-ranked
business school, demonstrated higher GMAT scores in evening
types even within a high achieving group50. However, it is
possible these results are impacted by misclassiﬁcation in our self-
reported measurement of chronotype. Although the question
clearly asks for preference, participants might have been
inﬂuenced by the reality of their working lives. Those from
more deprived socioeconomic positions might have occupations
that are more restrictive in terms of working hours and hence
less able to ‘adhere’ to their preference. If this results in a
relationship between socioeconomic position and
misclassiﬁcation then socioeconomic position would confound
any observational associations. However, since participants are
extremely unlikely to know their genotype for the variants we
have identiﬁed, any misclassiﬁcation of chronotype by genotype
will be random with the expectation that the genetic correlation
and Mendelian randomization studies would be biased towards
the null.
Our study is well-powered to detect genetic variants associated
with chronotype, with previous studies demonstrating the power
of a sample size 4100,000 for detecting genetic effects51.
The study uses a single harmonized question across a large
cohort, which is in contrast with previous studies that needed to
harmonize data across several cohorts with varying measures
of chronotype. Our measure of chronotype is based on
self-identiﬁcation, and may reﬂect timing preference more so
than objective measures of chronotype and since it does
not take weekday and weekend behaviour into account,
any misclassiﬁcation may be related to occupation and/or
socioeconomic position. However, as noted above, for our
genetic correlation and Mendelian randomization analyses this
would be expected to bias ﬁndings towards the null. Our cohort is
aged 40 to 69 years and of European ancestry, which reduces the
likelihood of bias due to population structure, but means we
cannot necessarily assume our results generalize to other groups.
That said the distribution of chronotype is consistent with that
found in previous studies52–54.
In summary, in a large-scale GWAS of chronotype, we
identiﬁed 12 new genetic loci that implicate known components
of the circadian clock machinery and point to previously
unstudied genetic variants and candidate genes that might
modulate core circadian rhythms or light-sensing pathways.
Furthermore, genome-wide analysis suggests that chronotype
shares underlying genetic pathways with educational attainment,
schizophrenia and possibly BMI, and that evening chronotype
might be causally related to higher educational attainment. This
work should advance biological understanding of the molecular
processes underlying circadian rhythms, and open avenues for
future research in the potential of modulating circadian biology to
aide prevention and treatment of associated diseases.
Methods
Population and study design. Study participants were from the UK Biobank
study, described in detail elsewhere55. In brief, the UK Biobank is a prospective
study of4500,000 people living in the United Kingdom. All people in the National
Health Service registry who were aged 40–69 years and living o25 miles from a
study centre were invited to participate between 2006 and 2010. In total, 503,325
participants were recruited from over 9.2 million mailed invitations. Self-reported
baseline data was collected by questionnaire and anthropometric assessments were
performed. For the current analysis, individuals of non-white ethnicity were
excluded to avoid confounding effects.
Chronotype and covariate measures. Study subjects self-reported chronotype,
sleep duration, depression, medication use, age, and sex on a touch-screen
questionnaire. Chronotype was derived from responses to a chronotype question
that participants answered, along with other study questions, on a touch-screen
computer at each assessment centre. The question was taken from the
Morningness–Eveningness questionnaire; it is the question from that questionnaire
that explains the highest fraction of variance in preferences in sleep–wake timing
and is an accepted measure of chronotype54. The question asks: ‘Do you consider
yourself to bey’ with response options ‘Deﬁnitely a ‘morning’ person’, ‘More
a ‘morning’ than ‘evening person’, ‘More an ‘evening’ than a ‘morning’ person’,
‘Deﬁnitely an ‘evening’ person’, ‘Do not know’, ‘Prefer not to answer’. This
question speciﬁcally does not ask about actual sleeping pattern, nor does it
distinguish between weekday and weekend behaviour and was accessed at the time
of exam, which crosses days of the week and seasons across participants. In all,
498,450 subjects answered this question, but only the 153,000 with genetic data
were considered for this analysis. Subjects who responded ‘Do not know’ or ‘Prefer
not to answer’ were set to missing. Chronotype was treated both as a continuous
trait, with chronotype coded 1–4, where 1 represents deﬁnite morning chronotype,
and a dichotomous trait, with deﬁnite morning responders set to control
(n¼ 26,948) and deﬁnite evening responders set to case (n¼ 8,724). Depression
was reported in answer to the question ‘How often did you feel down, depressed or
hopeless mood in last 2 weeks?’ (cases, n¼ 4,279). Subjects with self-reported shift
work (n¼ 22,165) or sleep medication use (n¼ 4,575) were excluded.
Genotyping and quality control. Of the B500,000 subjects with phenotype data
in the UK Biobank,B153,000 are currently genotyped. Genotyping was performed
by the UK Biobank, and genotyping, quality control and imputation procedures are
described in detail here56. In brief, blood, saliva and urine were collected from
participants, and DNA was extracted from the buffy coat samples. Participant
DNA was genotyped on two arrays, UK BiLEVE and UKB Axiom with 495%
common content and genotypes for B800,000 SNPs were imputed to the UK10K
reference panel. Genotypes were called using Affymetrix Power Tools software.
Sample and SNP quality control were performed. Samples were removed for
high missingness or heterozygosity (480 samples), short runs of homozygosity
(8 samples), related individuals (1,856 samples) and sex mismatches (191 samples).
Genotypes for 152,736 samples passed sample quality control (B99.9% of total
samples). SNPs were excluded if they did not pass quality control ﬁlters across all
33 genotyping batches, with a missingness threshold of 0.90. Batch effects were
identiﬁed through frequency and Hardy–Weinberg equilibrium tests (P value
o10 12). Before imputation, 806,466 SNPs pass quality control in at least one
batch (499% of the array content). Population structure was captured by principal
component analysis on the samples using a subset of high quality (missingness
o1.5%), high-frequency SNPs (42.5%) (B100,000 SNPs) and identiﬁed the
sub-sample of European descent. Imputation of autosomal SNPs was performed to
a merged reference panel of the Phase 3 1000 Genome Project and the UK10K
using IMPUTE3 (ref. 57). Data was prephased using SHAPEIT3 (ref. 58). In total,
73,355,677 SNPs, short indels and large structural variants were imputed. Post-
imputation quality control was performed as previously outlined and an info score
cutoff of 0.1 was applied. For GWAS, we further excluded SNPs with minor allele
frequency (MAF) o0.00016, a threshold that represents a minimum 50 counts of
each genotype, a conservative threshold. In total, 100,400 samples of European
descent with high-quality genotyping and complete phenotype/covariate data were
used for these analyses. Genotyping quality of two signiﬁcant rare SNPs (rs1144566
and rs35333999) was veriﬁed by examination of genotyping intensity cluster plots
(Supplementary Fig. 5). In addition, for two signiﬁcant imputed rare SNPs we
checked Information Quality Scores (info) and found these to be above the
standard threshold of 0.40 used to indicate good imputation quality59 (rs141175086
info¼ 0.48 and rs148750727 info¼ 0.88). Considering the size of the genotyped
UK Biobank cohort (NB150,000), an information measure of 0.4 on a sample of
150,000 individuals indicates that the amount of data at the imputed SNP is
roughly equivalent to perfectly observed genotype data in a sample of NB60,000.
Statistical analysis. Genetic association analysis was performed in SNPTEST60
with the ‘expected’ method using an additive genetic model adjusted for age, sex,
10 principal components of ancestry and genotyping array. Genome-wide
association analysis was performed separately for continuous chronotype and
‘extreme’ chronotype with a genome-wide signiﬁcance threshold of 5 10 8.
Follow-up analyses on genome-wide signiﬁcant loci included sex interaction testing
using a linear regression model including a sex*SNP interaction term, performed in
R61, and conditional analysis using SNPTEST conditioning on the lead signal in
each locus ±500 kb, covariate sensitivity analysis individually adjusting for sleep
duration, sleep disorders, insomnia and depression/psychiatric medication use.
Heritability was calculated using BOLT-Reml62. Post-GWAS analysis of LD Score
Regression (LDSC)29,34,63,64 was conducted using all UK Biobank SNPs also found
in HapMap3 and included publicly available data from 19 published genome-wide
association studies, with a P value threshold of 0.0026 after Bonferroni correction
for all 19 tests performed. Gene-based testing was performed using VEGAS31 on
GWAS summary statistics from SNPs and samples passing rigorous quality
control, and gene-set enrichment of genes signiﬁcant after Bonferroni correction
was performed using Web-Gestalt32. Given that gene-based tests like VEGAS are
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sensitive to missing data and may show inﬂation and low power if data for rare
variants is missing65, we note low missingness rates (480% of SNPs had over
99.5% genotyping call rate), and foro5% of SNPs that may have failed in a subset
of 33 batches, imputation was used to infer missing genotypes. Furthermore, our
gene-based testing included only single SNP association results for variants with
over 50 minor allele counts. A Q–Q plot of inﬂation-adjusted gene-based results for
17,791 genes is shown in Supplementary Fig. 3. Pathway-based analysis to identify
enrichment in biological processes, gene sets and tissues suggested by the top loci
was performed in DEPICT33 for all SNPs present in 1KG phase 3 (ref. 66).
For Mendelian randomization analyses, the weighted genetic risk score was
calculated by summing the products of the chronotype risk allele count for 15 SNPs
multiplied by the scaled chronotype effect reported by 23andMe18 (that is, using
weights from study independent from our own). The instrumental variable
analyses were performed in R40 using the two-stage-least-squares method
(TSLS function in the SEM package). The risk scores for education, schizophrenia
and BMI were constructed using the GWS SNPs and weights from previously
published GWAS67–69 and tested on chronotype using the summary statistics from
our reported GWAS using the GTX package in R.
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